Holen Sie sich die Stockscreener-App
40.86
0.10%
0.10
Atricure Inc Aktie (ATRC) Neueste Nachrichten
Transcatheter Aortic Valve Replacement Market Future Business - openPR
AtriCure, Inc. (NASDAQ:ATRC) Shares Purchased by Calamos Advisors LLC - MarketBeat
Atrial Fibrillation Systems Market Witness Booming Demand: - openPR
AtriCure (NASDAQ:ATRC) Stock Price Down 4.9%Should You Sell? - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of “Buy” by Brokerages - Defense World
AtriCure (NASDAQ:ATRC) Sets New 1-Year HighHere's What Happened - MarketBeat
Why AtriCure, Inc. (ATRC) Is Skyrocketing Now - MSN
AtriCure (NASDAQ:ATRC) Price Target Raised to $51.00 - Defense World
Trading (ATRC) With Integrated Risk Controls - Stock Traders Daily
AtriCure (NASDAQ:ATRC) Hits New 52-Week High Following Analyst Upgrade - MarketBeat
Needham reiterates Buy on AtriCure shares amid impressive growth and solid valuation - MSN
Revenues Tell The Story For AtriCure, Inc. (NASDAQ:ATRC) As Its Stock Soars 29% - Simply Wall St
AtriCure (NASDAQ:ATRC) Price Target Raised to $51.00 at Needham & Company LLC - MarketBeat
AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results - Business Wire
Deep Dive Into AtriCure Stock: Analyst Perspectives (9 Ratings) - Benzinga
Assenagon Asset Management S.A. Has $4.25 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC) - Defense World
Assenagon Asset Management S.A. Sells 90,029 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Atrial Fibrillation Surgery Market Trends & Insights 2025 -2033 - openPR
AtriCure stock soars to 52-week high, hits $39.08 - MSN
Orthofix Medical (NASDAQ:OFIX) vs. AtriCure (NASDAQ:ATRC) Head-To-Head Contrast - Defense World
AtriCure (NASDAQ:ATRC) Hits New 52-Week HighShould You Buy? - MarketBeat
AtriCure stock soars to 52-week high, hits $39.08 By Investing.com - Investing.com South Africa
AtriCure reports preliminary results for fourth quarter - MSN
AtriCure (ATRC) Stock Surges Over 5% Amid Market Activity - GuruFocus.com
AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by JPMorgan Chase & Co. - MarketBeat
AtriCure projects growth, sets 2025 financial targets By Investing.com - Investing.com Australia
AtriCure projects growth, sets 2025 financial targets - Investing.com
Needham retains AtriCure stock buy rating after revenue beat By Investing.com - Investing.com Australia
AtriCure Q4 revenue prelims beat The Street - Mass Device
Long Term Trading Analysis for (ATRC) - Stock Traders Daily
AtriCure Inc (ATRC) Shares Up 5.13% on Jan 13 - GuruFocus.com
AtriCure (NASDAQ:ATRC) Shares Gap UpShould You Buy? - MarketBeat
AtriCure's (ATRC) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
Needham retains AtriCure stock buy rating after revenue beat - Investing.com India
AtriCure (NASDAQ:ATRC) Issues FY 2024 Earnings Guidance - MarketBeat
AtriCure Projects Strong Revenue Growth for 2024 - TipRanks
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day - Business Wire
AtriCure, Inc. (NASDAQ:ATRC) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
AtriCure, Inc. (NASDAQ:ATRC) Given Average Rating of “Buy” by Analysts - Defense World
0.73%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):